This inventor holds 1 USPTO granted patent. Top assignee: Northwestern University. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Michael Schwake: Innovator in Lysosome Membrane Protein Research
Introduction
Michael Schwake is a prominent inventor based in Chicago, IL (US). He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic peptides. His work focuses on lysosome membrane protein 2 (LIMP-2) and its related applications.
Latest Patents
Michael Schwake holds a patent for "Lysosome membrane protein 2 (LIMP-2) based peptides and related uses." This patent describes a group of LIMP-2 peptides, LIMP-2 polypeptides, and their variants. The disclosed peptides and polypeptides are designed to provide biological activity associated with LIMP-2. This includes the ability to bind and activate biological molecules such as β-glucocerebrosidase and binding viral protein 1 (VP1) of enterovirus 71 (E71) or coxsackievirus A16 (CA16). Additionally, the patent outlines methods for using these LIMP-2 peptides and polypeptides as therapeutics for treating diseases linked to β-glucocerebrosidase activity.
Career Highlights
Michael Schwake is affiliated with Northwestern University, where he conducts his research. His innovative work has led to advancements in understanding the therapeutic potential of LIMP-2 peptides. He has been recognized for his contributions to the scientific community and continues to explore new avenues for research and development.
Collaborations
One of his notable collaborators is Dimitri Krainc. Their partnership has fostered advancements in the understanding of lysosomal functions and their implications in various diseases.
Conclusion
Michael Schwake's work in the field of lysosome membrane protein research exemplifies the impact of innovative thinking in biochemistry. His patent on LIMP-2 based peptides highlights the potential for new therapeutic approaches in treating related diseases.